CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $91,671,669
- in 32 filings, $73.3M under 10b5-1 plans
Net −$91,671,669. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Leproust Emily M. −$76.4M Chief Executive Officer sold 43% of stake
- Finn Patrick John −$6.8M President and COO sold 16% of stake
- Green Paula −$2.6M SVP of Human Resources sold 23% of stake
- Cho Dennis −$2.6M Reporting owner sold 17% of stake
- Laponis Adam −$2.6M Chief Financial Officer sold 12% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | CHESS ROBERT Director | Exercise or conversion 10b5-1 | +18,417 | $11.89 | $219K | 39,501 |
| 2026-08-07 | CHESS ROBERT Director | Sale 10b5-1 | −18,417 | $110.89 | $2.0M | 21,084 |
| 2026-08-07 | CHESS ROBERT Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −18,417 | 0 | ||
| 2026-03-17 | CHESS ROBERT Director | Exercise or conversion 10b5-1 | +10,000 | $11.89 | $119K | 31,084 |
| 2026-03-17 | CHESS ROBERT Director | Sale 10b5-1 | −10,000 | $47.00 | $470K | 21,084 |
| 2026-03-17 | CHESS ROBERT Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −10,000 | 18,417 | ||
| 2026-02-13 | CHESS ROBERT Director | Sale | −2,184 | $48.26 | $105K | 21,084 |
| 2026-02-05 | CHESS ROBERT Director | Grant or award | +5,095 | 23,268 | ||
| 2025-02-07 | CHESS ROBERT Director | Sale | −2,940 | $53.14 | $156K | 18,173 |
| 2025-02-05 | CHESS ROBERT Director | Grant or award | +4,472 | 21,113 | ||
| 2025-01-07 | CHESS ROBERT Director | Sale 10b5-1 | −5,000 | $50.00 | $250K | 16,641 |
| 2024-12-05 | CHESS ROBERT Director | Exercise or conversion 10b5-1 | +3,504 | $8.82 | $31K | 25,145 |
| 2024-12-05 | CHESS ROBERT Director | Sale 10b5-1 | −2,795 | $51.70 | $145K | 22,350 |
| 2024-12-05 | CHESS ROBERT Director | Sale 10b5-1 | −709 | $52.45 | $37K | 21,641 |
| 2024-12-05 | CHESS ROBERT Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,504 | 0 | ||
| 2024-11-11 | CHESS ROBERT Director | Exercise or conversion 10b5-1 | +3,600 | $8.82 | $32K | 25,241 |
| 2024-11-11 | CHESS ROBERT Director | Sale 10b5-1 | −2,324 | $46.99 | $109K | 22,917 |
| 2024-11-11 | CHESS ROBERT Director | Sale 10b5-1 | −1,276 | $47.76 | $61K | 21,641 |
| 2024-11-11 | CHESS ROBERT Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −3,600 | 3,504 | ||
| 2024-02-08 | CHESS ROBERT Director | Sale | −4,110 | $34.98 | $144K | 64,169 |
Page 1 of 2 · 21 trades